Category Archives: IPR

EU-Mercosur FTA puts at risk access to medicines in Brazil, new impact assessment study finds

EU-Mercosur FTA puts at risk access to medicines in Brazil, new impact assessment study finds Authors: Marcela Fogaça Vieira – human rights and IP lawyer, master in Public Health, consultant Shuttleworth Foundation Gabriela Costa Chaves – pharmacist, PhD in public … Continue reading

Posted in EU Mercosur FTA, IPR, Uncategorized | Leave a comment

India Will Not Cross Red Lines on Generic Drugs in RCEP, but Stay Vigilant, Say Officials

Source: The Wire Healthcare watchers are calling on India to resist the free trade agreement’s provisions which could compromise India’s ability to keep supplying cheaper generic drugs to the world. Hundreds of government officials and activists huddle separately in South … Continue reading

Posted in Data Exclusivity, Generics, IPR, Patent, Patent Term Extension, Regional Comprehensive Economic Partnership, Uncategorized | Leave a comment

Facebook Twitter Whatsapp Intellectual Property for the Twenty-First-Century Economy

Source: Project Syndicate Developing countries are increasingly pushing back against the intellectual property regime foisted on them by the advanced economies over the last 30 years. They are right to do so, because what matters is not only the production … Continue reading

Posted in IPR, Patent, TRIPS, TRIPS flexibilities, Uncategorized | Leave a comment

US needs to push range of economic issues with India: Kenneth Juster

Source: The Economic Times WASHINGTON: The US must push a range of economic issues with India, including intellectual property, standard and non-tariff barriers, President Donald Trump’s nominee to be the next envoy to India has told lawmakers. Underlining that there … Continue reading

Posted in Compulsory Licensing, IPR, Uncategorized | Leave a comment

Seven Decades of Grappling With Intellectual Property Issues in India

Create, Copy, Disrupt: India’s Intellectual Property Dilemmas is well-researched and easy to read, especially for a non-legal audience. By Jayashree Watal, The Wire The book Create, Copy, Disrupt: India’s Intellectual Property Dilemmas (OUP, 2017) is a serious effort by two legal scholars, Prashant … Continue reading

Posted in IPR, TRIPS, TRIPS flexibilities, TRIPS plus, TRIPS&IP rights, Uncategorized | Leave a comment

Draft Pharmaceutical Policy, 2017

Source: All India Drug Action Network (AIDAN) The Department of Pharmaceuticals has circulated a Draft Pharmaceutical Policy, 2017 which can be accessed here. The draft policy identifies the following key objectives: a. Making essential drugs accessible at affordable prices to the … Continue reading

Posted in API, Biologics/Biosimilars, Evergreening, Innovation, IPR, Patent, R&D, Uncategorized | Leave a comment

South African IP policy draft released seeking comments from public

International Trade and Economic Development division of South African Government has released the  Draft Intellectual Property Policy of the Republic of south Africa Phase 2017 and it is now publicly available for comments.  Access the draft policy here: http://www.dti.gov.za/gazzettes/IP_Policy.pdf   

Posted in IPR, R&D, TRIPS, TRIPS flexibilities, TRIPS plus, Uncategorized | Leave a comment